Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes.
Journal: Future oncology (London, England)
Published: October 19, 2020
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
Journal: The New England journal of medicine
Published: June 02, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: March 22, 2015
Immunologic correlates of the abscopal effect in a patient with melanoma.
Journal: The New England journal of medicine
Published: March 09, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026